Recombinant IL6 (Ziltivekimab Biosimilar) antibody

Catalog No. ABIN7488257

This anti-IL6 (Ziltivekimab Biosimilar) antibody is a Mammalian Cells Monoclonal antibody detecting IL6 (Ziltivekimab Biosimilar) in ELISA. Suitable for Human.

Quick Overview for Recombinant IL6 (Ziltivekimab Biosimilar) antibody (ABIN7488257)

Target: IL6 (Ziltivekimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL6 (Ziltivekimab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL6 (Ziltivekimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Ziltivekimab Biosimilar - Anti-IL6 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL6 (Ziltivekimab Biosimilar)

Target: IL6 (Ziltivekimab Biosimilar)

Target Type: Biosimilar

Background: COR-001
Ziltivekimab is a proprietary anti-interleukin-6 ligand monoclonal antibody (anti-IL6 mAb), targeting residual inflammatory cardiovascular risk in patients living with advanced chronic kidney disease (CKD).

CAS-No: 2226654-05-1